Cite
Aggarwal C, Cohen RB, Morrow MP, et al. Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis. Vaccines (Basel). 2020;8(1)doi: 10.3390/vaccines8010056.
Aggarwal, C., Cohen, R. B., Morrow, M. P., Kraynyak, K. A., Sylvester, A. J., Cheung, J., Dickerson, K., Schulten, V., Knoblock, D., Gillespie, E., Bauml, J. M., Yan, J., Diehl, M., Boyer, J., Dallas, M., Kim, J. J., Weiner, D. B., & Skolnik, J. M. (2020). Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis. Vaccines, 8(1), . https://doi.org/10.3390/vaccines8010056
Aggarwal, Charu, et al. "Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis." Vaccines vol. 8,1 (2020). doi: https://doi.org/10.3390/vaccines8010056
Aggarwal C, Cohen RB, Morrow MP, Kraynyak KA, Sylvester AJ, Cheung J, Dickerson K, Schulten V, Knoblock D, Gillespie E, Bauml JM, Yan J, Diehl M, Boyer J, Dallas M, Kim JJ, Weiner DB, Skolnik JM. Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis. Vaccines (Basel). 2020 Jan 29;8(1). doi: 10.3390/vaccines8010056. PMID: 32013270; PMCID: PMC7158680.
Copy
Download .nbib